Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bernard Escudier(Institut Gustave Roussy), Vesa Kataja(Kuopio University Hospital), Peter F.A. Mulders(Radboud University Nijmegen), Vincent Khoo(The University of Texas MD Anderson Cancer Center), Ferrán Algaba(Puigvert Foundation), Camillo Porta(University of Pavia), J.-J. Patard(Bicêtre Hospital), Tim Eisen(NIHR Cambridge Biomedical Research Centre)
Cited by 275
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k